59 related articles for article (PubMed ID: 2459015)
1. Pharmacokinetics of plasmatic plasminogen activator in rabbits.
González Rey JR; Cuevas Valdespino M; Cardona M; Díaz A; Gongora C; Pérez B; Sánchez J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):171-6. PubMed ID: 2459015
[TBL] [Abstract][Full Text] [Related]
2. The use of active centre acylation to control the pharmacokinetic profile of a recombinant chimaeric plasminogen activator.
Wilson S; Cronk DW; Dodd I; Esmail AF; Kalindjian SB; McMurdo L; Browne MJ; Smith RA; Robinson JH
Thromb Haemost; 1993 Dec; 70(6):984-8. PubMed ID: 8165622
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of single doses of gentamicin given by intravenous and intramuscular routes to lactating cows.
Haddad NS; Ravis WR; Pedersoli WM; Carson RL
Am J Vet Res; 1986 Apr; 47(4):808-13. PubMed ID: 3754403
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of ketoprofen in healthy foals less than twenty-four hours old.
Wilcke JR; Crisman MV; Scarratt WK; Sams RA
Am J Vet Res; 1998 Mar; 59(3):290-2. PubMed ID: 9522947
[TBL] [Abstract][Full Text] [Related]
5. Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species: a comparison of mathematical models.
Godfrey KR; Tanswell P; Bates RA; Chappell MJ; Madden FN
Biopharm Drug Dispos; 1998 Mar; 19(2):131-40. PubMed ID: 9533114
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activators: a comparison.
Baruah DB; Dash RN; Chaudhari MR; Kadam SS
Vascul Pharmacol; 2006 Jan; 44(1):1-9. PubMed ID: 16275118
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics of cefamandole in rabbits].
Klimova VS; Bobrov VI; Nazarova OI; Skala LZ; Iakovlev VP
Antibiotiki; 1982 Dec; 27(12):34-8. PubMed ID: 7165292
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of gentamicin in the horse.
Pedersoli WM; Belmonte A; Purohit RC; Ravis WR
Am J Vet Res; 1980 Mar; 41(3):351-4. PubMed ID: 7369607
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of prethcamide following rapid intravenous injection and oral administration in rabbits.
Bryła P; Szumiło T
Pol J Pharmacol Pharm; 1985; 37(5):653-61. PubMed ID: 3832011
[TBL] [Abstract][Full Text] [Related]
10. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of gentamicin in laboratory rabbits.
Curl JL; Curl JS
Am J Vet Res; 1988 Dec; 49(12):2065-7. PubMed ID: 3239843
[TBL] [Abstract][Full Text] [Related]
12. [Acute pharmacokinetics of the Tl+ ion in the rabbit. 3-compartment model].
Morales-Aguilera A; Careaga Olivares J
Arch Invest Med (Mex); 1990; 21(3):263-7. PubMed ID: 2131775
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep, and cows.
Bregante MA; Saez P; Aramayona JJ; Fraile L; Garcia MA; Solans C
Am J Vet Res; 1999 Sep; 60(9):1111-6. PubMed ID: 10490081
[TBL] [Abstract][Full Text] [Related]
14. New method that gives true least squares fit of one and two compartment open pharmacokinetic models applied to valproic acid and methadone.
Lawyer CH; Gerber N
Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):253-68. PubMed ID: 6777838
[TBL] [Abstract][Full Text] [Related]
15. Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
Bae SK; Lee SJ; Kim YG; Kim SH; Kim JW; Kim T; Lee MG
Biopharm Drug Dispos; 2005 Apr; 26(3):99-115. PubMed ID: 15723427
[TBL] [Abstract][Full Text] [Related]
16. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.
Dagrosa EE; Hajdú P; Malerczyk V; de Looze S; Seeger K; Grötsch H
Clin Ther; 1987; 10(1):18-31. PubMed ID: 3450392
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of physostigmine in the rat after intravenous administration.
Somani SM; Khalique A
Drug Metab Dispos; 1987; 15(5):627-33. PubMed ID: 2891478
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of vincristine sulfate in adult cancer patients.
Sethi VS; Jackson DV; White DR; Richards F; Stuart JJ; Muss HB; Cooper MR; Spurr CL
Cancer Res; 1981 Sep; 41(9 Pt 1):3551-5. PubMed ID: 7260915
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator (rt-PA) in humans.
Verstraete M; Bounameaux H; de Cock F; Van de Werf F; Collen D
J Pharmacol Exp Ther; 1985 Nov; 235(2):506-12. PubMed ID: 4057083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
